Rare diseases
Investigational molecules
Locations
825 Industrial Road Suite 100, 94070-3303, United States
Iovance Biotherapeutics Inc. is active in clinical research for melanoma, including previously treated advanced melanoma and untreated advanced melanoma. Its studies also extend to treatment settings where tumor-infiltrating lymphocytes are used alone or alongside immune checkpoint inhibitors.
The sponsor’s melanoma-focused trials include both standalone and combination cell therapy approaches aimed at solid tumor disease control.
Iovance Biotherapeutics Inc. runs clinical trials in conditions such as Malignant melanoma, Non-small cell lung cancer, Non-small cell lung cancer metastatic, Cervix carcinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgium
FranceFrance
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
